MPM BioVentures 2014, L.P.'s Form 4 filing
Werewolf Therapeutics, Inc. (HOWL) · filed Nov 12, 2025
- Accession no.
- 0001231919-25-000461
- Filed
- Nov 12, 2025, 7:32 PM ET
- Trade date
- Nov 7-12, 2025
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions. Open-market sales total $241.3K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| MPM BioVentures 2014, L.P.CIK 0001609492 | 10% Owner |
| MPM BioVentures 2014 (B), L.P.CIK 0001609493 | 10% Owner |
| MPM Asset Management Investors BV2014 LLCCIK 0001609495 | 10% Owner |
| MPM BioVentures 2014 LLCCIK 0001765021 | 10% Owner |
| MPM BioVentures 2014 GP LLCCIK 0001765091 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2025 | Common Stock | SSaleDisposed | −68,480 | $1.11 | −$76,012.8 | 5,836,240 | Indirect | Duplicate filing |
| Nov 10, 2025 | Common Stock | SSaleDisposed | −48,570 | $1.18 | −$57,312.6 | 5,787,670 | Indirect | Duplicate filing |
| Nov 11, 2025 | Common Stock | SSaleDisposed | −55,810 | $1.14 | −$63,623.4 | 5,731,860 | Indirect | Duplicate filing |
| Nov 12, 2025 | Common Stock | SSaleDisposed | −40,669 | $1.09 | −$44,329.21 | 5,691,191 | Indirect | Duplicate filing |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.